Receiver

New Genialis RNA Biomarker Accurately Predicts KRAS Outcomes in Lung Cancer Patients

Retrieved on: 
Tuesday, April 9, 2024
Software, Research, Pharmaceutical, Oncology, Data Management, Technology, Artificial Intelligence, Genetics, Clinical Trials, Science, Biotechnology, Health, Cancer, AUROC, Disease, Progression-free survival, Patient, Lung, Biomarker, RNA, EAP, Doctor of Philosophy, Biology, AACR, Receiver, Neoplasm, Drug development, FDA, Annual general meeting, Pharmaceutical industry

Genialis , the RNA-biomarker company, today presented a poster on a new AI/ML classifier, Genialis™ krasID, that accurately predicts clinical benefit in a real-world cohort of patients who received sotorasib, a KRAS inhibitor currently approved for KRAS G12C non-small cell lung cancers.

Key Points: 
  • Genialis , the RNA-biomarker company, today presented a poster on a new AI/ML classifier, Genialis™ krasID, that accurately predicts clinical benefit in a real-world cohort of patients who received sotorasib, a KRAS inhibitor currently approved for KRAS G12C non-small cell lung cancers.
  • Genialis krasID analyzes foundational aspects of KRAS biology using RNA-sequencing and a machine learning algorithm comprising numerous biologic signatures.
  • Taken together, these early results demonstrate that the Genialis krasID classifier can predict response and stratify durable benefit in experimental and clinical settings.
  • Last week, Genialis announced the addition of two new partners as it assembles the world’s most ethnographically diverse cancer data sets .

Signature Resolution Welcomes Hon. Mitchell Beckloff (Ret.) to Panel of Neutrals

Retrieved on: 
Tuesday, April 9, 2024
Writ, Receiver, RET, Communication, Private sector, Court, Loyola Law School, Bruce's Beach, LOS, Superior court, UCLA

LOS ANGELES, April 8, 2024 /PRNewswire-PRWeb/ -- Signature Resolution, a leader in alternative dispute resolution, is pleased to announce the addition of Hon. Mitchell Beckloff (Ret.) to its panel of neutrals. After an illustrious judicial career that spanned over two decades on the Los Angeles County Superior Court bench, Judge Beckloff brings a wealth of experience and a deep understanding of civil, probate, and family law matters.

Key Points: 
  • I am eager to leverage my experience to facilitate constructive resolutions and uphold the integrity of the legal process at Signature Resolution."
  • "My journey from the bench to Signature Resolution marks a transition fueled by a passion for effective dispute resolution," said Judge Beckloff.
  • "We are thrilled to welcome Judge Beckloff to Signature Resolution," said Dario Higuchi, Signature Resolution founding partner and managing member.
  • In his role at Signature Resolution, Judge Beckloff aims to utilize his extensive judicial experience to facilitate fair, efficient, and effective dispute resolution.

Innovating "Treadmill Exercise Test AI-Assisted Interpretation System," CMUH(Taiwan) Timely Saves More Patients with Severe Myocardial Infarction

Retrieved on: 
Tuesday, April 2, 2024
Depression, Thrombosis, Myocardial infarction, Sudden death, Cardiovascular disease, Exercise, Survival, Coronary artery disease, ECG, Hyperlipidemia, Patient, Palpitations, Angina, Cancer, AI, Death, Moyamoya disease, Chronic pain, Plaque, Diet, Receiver, Smoking, Cardiac catheterization, Stenosis, Oxygen, Heart, Atherosclerosis, Rupture, Ministry, Duke, Vascular occlusion, CAD

To address this issue, China Medical University Hospital (CMUH) AI Center successfully developed the "Treadmill Exercise Test AI-Assisted Interpretation System" which was trained with nearly a thousand treadmill ECG, in patients with coronary arterystenosisover 70% shown on their coronary angiography.

Key Points: 
  • To address this issue, China Medical University Hospital (CMUH) AI Center successfully developed the "Treadmill Exercise Test AI-Assisted Interpretation System" which was trained with nearly a thousand treadmill ECG, in patients with coronary arterystenosisover 70% shown on their coronary angiography.
  • The program also utilizes ten measured features and two derived features including maximal work output and peak heart rate to determine the severity of coronary artery stenosis.
  • Generally, coronary heart disease in patients of middle or senior age is presented as angina or myocardial infarction and is one of the primary causes of sudden death."
  • Dr. Wu stated, "Coronary artery stenosis is a multi-factorial condition related to smoking, advanced age, diabetes hypertension and hyperlipidemia.

Reliability Incorporated (RLBY) Updates Investors on the Ongoing Litigation against the Vivos Group.

Retrieved on: 
Thursday, March 7, 2024
MMG, Receiver, Arbitral tribunal, Circuit court, Ridesharing

The arbitrator also appointed a rehabilitative receiver to collect Reliability’s portion of the judgments.

Key Points: 
  • The arbitrator also appointed a rehabilitative receiver to collect Reliability’s portion of the judgments.
  • Thus, Reliability and MMG now, have final judgments which the appointed Receiver is now eligible to collect.
  • The Rehabilitative Receiver appointed by the Arbitrator is currently working on a plan to enable Reliability to collect the Awards.
  • During the receivership, Vivos Group shareholders shall not be entitled to vote any of their shares in Reliability at any annual or special meetings of the shareholders.

Allen D. Applbaum, Partner at StoneTurn, Appointed Receiver of ArciTerra Companies, LLC

Retrieved on: 
Wednesday, January 10, 2024
Professional Services, Legal, Business, Record, Receiver, Partner, P.C, Book, District court, Receivership, Jennifer Larmore, Security (finance), Cryptocurrency

On December 21, 2023, the U.S. District Court for the District of Arizona appointed Allen D. Applbaum , a Partner at StoneTurn, as the Receiver of ArciTerra Companies, LLC and its related affiliates (“ArciTerra”), in connection with an alleged $35 million misappropriation of funds by Phoenix-Area Real Estate Fund Adviser Jonathan Larmore and affiliates.

Key Points: 
  • On December 21, 2023, the U.S. District Court for the District of Arizona appointed Allen D. Applbaum , a Partner at StoneTurn, as the Receiver of ArciTerra Companies, LLC and its related affiliates (“ArciTerra”), in connection with an alleged $35 million misappropriation of funds by Phoenix-Area Real Estate Fund Adviser Jonathan Larmore and affiliates.
  • The SEC’s complaint, filed on November 28, 2023, alleges, among other things, that since at least January 2017, Larmore and certain charged entities misappropriated more than $35 million from private real estate funds and other investment vehicles that ArciTerra managed.
  • The Receiver has retained Archer & Greiner, P.C., as his counsel, with the representation led by New York partner, Allen G. Kadish .
  • In order to centralize and address inquiries of investors, creditors and other affected parties, the Receiver has established the following email address, hotline, and website:

AONDevices™ Unveils AONx360™: A Pioneering Platform for High-Accuracy and Super Low-Power Edge AI Development

Retrieved on: 
Monday, January 8, 2024
Sound, CES, Data collection, Multimedia, Receiver

LAS VEGAS, Jan. 8, 2024 /PRNewswire/ -- AONDevices, a leader in super low-power, high-accuracy edge AI solutions, today announced the launch of AONx360™. This innovative online platform is set to redefine super low-power edge AI development, offering developers unparalleled tools for creating scalable, high-accuracy, super low-power edge AI applications.

Key Points: 
  • LAS VEGAS, Jan. 8, 2024 /PRNewswire/ -- AONDevices , a leader in super low-power, high-accuracy edge AI solutions, today announced the launch of AONx360™.
  • This innovative online platform is set to redefine super low-power edge AI development, offering developers unparalleled tools for creating scalable, high-accuracy, super low-power edge AI applications.
  • AONx360™, with its comprehensive suite of tools, dramatically accelerates development, ensuring quick time to market for Edge AI applications.
  • Mouna Elkhatib, CEO of AONDevices, said, "AONx360™ reflects our dedication to advancing super low-power edge AI, ensuring scalability and personalization for our customers.

New Research Shows High Accuracy of Precivity™ Blood Biomarkers in the Evaluation of Brain Amyloid in Pre-Clinical Alzheimer's Disease

Retrieved on: 
Tuesday, November 7, 2023
Biotechnology, Other Health, Health, General Health, Pharmaceutical, Neurology, Mental Health, Other Science, Research, Science, Clinical Trials, Physiology, Receiver, Plasma, AUC, Ageing, Biomarker, NP, Pathology, Disease, PET, University, APOE, Brain, Classification, Diagnosis, Patient, CI, Medical imaging, Neuroscience, Medicine

C2N analyzed the biomarkers using its high-resolution mass spectrometry (MS) analytical platform as part of this study.

Key Points: 
  • C2N analyzed the biomarkers using its high-resolution mass spectrometry (MS) analytical platform as part of this study.
  • All participants underwent amyloid PET scans, and 340 (32%) participants had positive PET scan findings (defined as Centiloid scale > 20).
  • Among the individual biomarkers evaluated, plasma p-tau217/np-tau217 had highest accuracy followed next by Aβ42/Aβ40 and last by p-tau181/np-tau181 for identifying amyloid PET status.
  • “The blood biomarkers with the highest performance in the study are the biomarkers highlighted in the Precivity blood tests, demonstrating the application of these biomarkers for important research purposes.

InterVenn Biosciences Announces the Publication of Early Detection of Advanced Adenoma and Colorectal Cancer in Gastroenterology, the Flagship Journal of the American Gastroenterological Association

Retrieved on: 
Friday, October 13, 2023
Technology, Medical Devices, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, Artificial Intelligence, Oncology, Diagnosis, NN, Partnership, Biomarker, Biology, Colorectal cancer, Receiver, CRC, Artificial intelligence, Workflow, Patient, AA, American Gastroenterological Association, Carolyn Bertozzi, Shaukat Khanum Memorial Cancer Hospital and Research Centre, LC-MS, Data analysis, Operating point, FP, Cancer, Research, Pharmaceutical industry, Medical imaging, Gastroenterology

InterVenn Biosciences , a life sciences company pioneering glycoproteomics, today announced the publication of their discovery work in Advanced Adenoma (AA) and Colorectal Cancer (CRC) early disease detection in the flagship journal of the American Gastroenterological Association, Gastroenterology.

Key Points: 
  • InterVenn Biosciences , a life sciences company pioneering glycoproteomics, today announced the publication of their discovery work in Advanced Adenoma (AA) and Colorectal Cancer (CRC) early disease detection in the flagship journal of the American Gastroenterological Association, Gastroenterology.
  • This groundbreaking research in early detection of CRC represents an advancement in early diagnosis through serum glycoproteome profiling.
  • The results published in Gastroenterology establish the groundwork for a blood-based CRC screening modality using artificial intelligence to reveal the earliest stages of colorectal cancer.
  • Desai K, Gupta S, May FP, Xu G, Shaukat A, Hommes DW, NICE-AA/CRC- Consortium, Early detection of advanced adenomas and colorectal carcinoma by serum glycoproteome profiling., Gastroenterology (2023), doi: https://doi.org/10.1053/j.gastro.2023.09.034

Fujitsu launches new technologies to protect conversational AI from hallucinations and adversarial attacks

Retrieved on: 
Tuesday, September 26, 2023
Benchmark, Data set, Sustainable Development Goal 9, Hallucination, United Nations, University, URL, Incubator, Synthetic media, Receiver, ML, Research, Sustainable Development Goals, Judgement, Ben-Gurion University of the Negev, Area, United, AI2, Generative, BGU, Curve, Observation, AI, API, Environment, Medical device, Phosphorus, Customer service, Mobile phone, Fujitsu

Professor Yuval Elovici, Ben Gurion University, comments: "Generative AI stands as a critical domain, and within it, the hallucination detection technology Fujitsu has developed emerges as pivotal for establishing trustworthy conversational AI systems.

Key Points: 
  • Professor Yuval Elovici, Ben Gurion University, comments: "Generative AI stands as a critical domain, and within it, the hallucination detection technology Fujitsu has developed emerges as pivotal for establishing trustworthy conversational AI systems.
  • Fujitsu will include these new technologies in its conversational AI core engine provided through the "Fujitsu Kozuchi (code name) - Fujitsu AI Platform," which offers users access to a wide range of powerful AI and ML technologies.
  • To address this issue, Fujitsu has developed a technology to detect manipulated URLs in the responses of conversational AI.
  • Fujitsu offers advanced technologies to corporate users via "Fujitsu Kozuchi (code name) - Fujitsu AI Platform" and to individual users through this portal site.

Signature Resolution Welcomes Hon. Mary H. Strobel (Ret.) to Panel of Neutrals

Retrieved on: 
Monday, September 25, 2023
Employment, University, USC School of Law, Education, Receiver, Superior court, Association of Business Trial Lawyers, Coif, CEQA, Mentorship, Administration, RET, Constitution, USC School of Architecture, Mitchell, Santa Claus, Practice of law

LOS ANGELES, Sept. 25, 2023 /PRNewswire-PRWeb/ -- Signature Resolution, a leader in alternative dispute resolution, announced today that Hon. Mary H. Strobel (Ret.) is joining the firm's prestigious panel of neutrals. With over forty years of legal experience, Judge Strobel will specialize in business, CEQA, complex litigation, Constitutional challenges, contract disputes and interpretation, employment, land use, public agency, and real property mediation.

Key Points: 
  • LOS ANGELES, Sept. 25, 2023 /PRNewswire-PRWeb/ -- Signature Resolution , a leader in alternative dispute resolution, announced today that Hon.
  • "I am truly excited and honored to join the exceptional team at Signature Resolution.
  • "I am truly excited and honored to join the exceptional team at Signature Resolution," said Judge Strobel.
  • Judge Strobel's wealth of experience makes her an ideal addition to Signature Resolution's esteemed panel of neutrals.